- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
CDC Updates Immunization Schedule
An update to the adult immunization schedule has been released by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice.
An update to the adult immunization schedule has been released by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice (ACIP) and published in Annals of Internal Medicine. The ACIP is comprised of the American College of Physicians and 16 other medical societies representing various medical practice areas. The update includes new information on pneumococcal, Tdap, and influenza vaccines.
Among the changes are:
• Mild egg allergy is no longer a contraindication to influenza vaccination, but these patients should get the inactivated flu shot.
• 13-valent pneumococcal conjugate vaccine (PCV13) had been added to the immunization schedule and should be used in combination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) for immunocompromised adults.
• Adults aged 65 years or older should now receive routine Tdap vaccinations.
The full immunization schedule can be viewed at http://annals.org/article.aspx?articleid=1567229.
